Cancer Research Technology

Cancer Research Technology (CRT) develops and commercializes exciting new discoveries in cancer research. They are at the intersection of academia and industry. Their deep understanding of both perspectives enables them to translate promising research into commercial propositions for maximum patient benefit and economic return.CRT has the unique advantage of fully leveraging the research and connections of its parent company, Cancer Research UK, the world’s largest charitable funder of cancer research, as well as their strong ties with leading global clinical and academic institutions, pharmaceutical companies, and biotechnology firms.With 30 years of expertise in the commercialization of cancer research, CRT boasts a proven track record of successful innovation.